Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer : a randomised controlled trialLancet (British edition). 1999, Vol 354, Num 9178, pp 533-540, issn 0140-6736Article

HER2 and responsiveness of breast cancer to adjuvant chemotherapyPRITCHARD, Kathleen I; SHEPHERD, Lois E; O'MALLEY, Frances P et al.The New England journal of medicine. 2006, Vol 354, Num 20, pp 2103-2111, issn 0028-4793, 9 p.Article

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women : A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1SAWKA, C. A; PRITCHARD, K. I; SHELLEY, W et al.Breast cancer research and treatment. 1997, Vol 44, Num 3, pp 211-215, issn 0167-6806Article

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcomaGORTZAK, E; AZZARELLI, A; KIRKPATRICK, A et al.European journal of cancer (1990). 2001, Vol 37, Num 9, pp 1096-1103, issn 0959-8049Article

Erlotinib in previously treated non-small-cell lung cancerSHEPHERD, Frances A; PEREIRA, José Rodrigues; VAN KOOTEN, Maximiliano et al.The New England journal of medicine. 2005, Vol 353, Num 2, pp 123-132, issn 0028-4793, 10 p.Article

Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 TrialMITTMANN, Nicole; AU, Heather-Jane; FINDLAY, Brian et al.Journal of the National Cancer Institute. 2009, Vol 101, Num 17, pp 1182-1192, issn 0027-8874, 11 p.Article

Vinorelbine plus Cisplatin vs. Observation in resected non-small-cell lung cancerWINTON, Timothy; LIVINGSTON, Robert; FRY, Willard et al.The New England journal of medicine. 2005, Vol 352, Num 25, pp 2589-2597, issn 0028-4793, 9 p.Article

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in Premenopausal women with node-positive breast cancerLEVINE, M. N; BRAMWELL, V. H; ARNOLD, A et al.Journal of clinical oncology. 1998, Vol 16, Num 8, pp 2651-2658, issn 0732-183XArticle

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanomaRUSTHOVEN, J. J; QUIRT, I. C; VERMA, S et al.Journal of clinical oncology. 1996, Vol 14, Num 7, pp 2083-2090, issn 0732-183XArticle

Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapyLATREILLE, J; PATER, J; WILLIAMS, C et al.Journal of clinical oncology. 1998, Vol 16, Num 3, pp 1174-1178, issn 0732-183XArticle

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastomaSTUPP, Roger; MASON, Warren P; CURSCHMANN, Jürgen et al.The New England journal of medicine. 2005, Vol 352, Num 10, pp 987-996, issn 0028-4793, 10 p.Article

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer : A report of the National Cancer Institute of Canada Clinical Trials GroupPRITCHARD, K. I; PATERSON, A. H. G; VERMA, S et al.Journal of clinical oncology. 1997, Vol 15, Num 6, pp 2302-2311, issn 0732-183XArticle